Financial Analysis: Vaxcyte Inc (PCVX)’s Ratios Unveil Key Insights

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Vaxcyte Inc’s stock clocked out at $91.05, up 0.69% from its previous closing price of $90.43. In other words, the price has increased by $0.69 from its previous closing price. On the day, 0.53 million shares were traded. PCVX stock price reached its highest trading level at $92.261 during the session, while it also had its lowest trading level at $90.22.

Ratios:

To gain a deeper understanding of PCVX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.

Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 09 ’24 when PICKERING GRANT sold 2,366 shares for $92.25 per share. The transaction valued at 218,253 led to the insider holds 136,215 shares of the business.

Eydelman Mikhail sold 5,000 shares of PCVX for $457,434 on Dec 05 ’24. The SVP, GEN COUNSEL & CORP SEC now owns 28,697 shares after completing the transaction at $91.49 per share. On Dec 09 ’24, another insider, PICKERING GRANT, who serves as the Officer of the company, bought 2,366 shares for $93.68 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 11348199424 and an Enterprise Value of 9195651072.

Stock Price History:

Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $53.83. The 50-Day Moving Average of the stock is -11.13%, while the 200-Day Moving Average is calculated to be 8.15%.

Shares Statistics:

It appears that PCVX traded 1.06M shares on average per day over the past three months and 866190 shares per day over the past ten days. A total of 124.43M shares are outstanding, with a floating share count of 120.31M. Insiders hold about 3.47% of the company’s shares, while institutions hold 107.36% stake in the company. Shares short for PCVX as of 1732838400 were 11032601 with a Short Ratio of 10.43, compared to 1730332800 on 8926077. Therefore, it implies a Short% of Shares Outstanding of 11032601 and a Short% of Float of 10.05.

Most Popular